Zhangyu K. Zou
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A modified frailty index to identify high-risk groups for amyotrophic lateral sclerosis.
Journal: Frontiers in neurology
Published: May 13, 2026
Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort Study.
Journal: Neurology and therapy
Published: March 13, 2026
Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: February 25, 2026
1-Year Clinical Outcome Post-Myasthenic Crisis: A Multicenter Prospective Study in China.
Journal: European journal of neurology
Published: October 06, 2025
Immune checkpoint changes correlate with the progression and prognosis of amyotrophic lateral sclerosis.
Journal: Annals of medicine
Published: August 04, 2025
Thyroid Disease and Amyotrophic Lateral Sclerosis.
Journal: Neuroepidemiology
Published: July 25, 2025
Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 05, 2025
Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: May 08, 2025
Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Journal: JAMA network open
Published: February 24, 2025
Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy.
Journal: Frontiers in neurology
Published: January 14, 2025
Associations of cachexia and frailty with amyotrophic lateral sclerosis.
Journal: Scientific reports
Published: December 06, 2024
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes.
Journal: Therapeutic advances in neurological disorders
Published: November 07, 2024
Last Updated: 09/26/2026